Department of Pediatrics, Apollo Hospital, Delhi, 110076, India.
Indian J Pediatr. 2012 Dec;79(12):1601-4. doi: 10.1007/s12098-012-0711-2. Epub 2012 Feb 29.
To assess the feasibility and complication rate associated with Subcutaneous Implantable Ports (SIPs) in pediatric cancer patients.
Ninety nine patients underwent chemo port insertion between January2003 to May 2011 with variety of neoplastic diseases. Data was collected with regards to underlying condition, duration the catheter was in situ and complications during insertion, accessing and removal. Chemoport was inserted either at diagnosis or once optimal conditions were achieved. Ports were placed in internal jugular vein (IJV) or subclavian vein (SCV) under general or local anesthesia under strict aseptic conditions in theatre.
A total of 100 ports were placed in 99 patients. The mean duration of the implantable ports was 393 days (range 30-1300). In 49 cases (49%), ports were removed electively, 15 cases (15%) died with port in situ and 36 cases (36%) still have port in situ and receiving chemotherapy without any complications. Complications observed were suspected infection (4%), port fracture (4%), thrombosis of catheter (1%) and blockage (1%).
The use of ports is safe and feasible in Pediatric Oncology patients if strict asepsis guidelines are followed.
评估在儿科癌症患者中使用皮下植入式端口（SIP）的可行性和并发症发生率。
2003 年 1 月至 2011 年 5 月期间，99 例患有各种肿瘤疾病的患者接受了化疗端口插入术。收集了与潜在疾病、导管在位时间以及插入、接入和移除过程中的并发症相关的数据。化疗端口在诊断时或在达到最佳条件后插入。端口在手术室中，在全身或局部麻醉下，根据严格的无菌条件，置于颈内静脉（IJV）或锁骨下静脉（SCV）中。
总共在 99 例患者中放置了 100 个端口。植入式端口的平均使用时间为 393 天（范围 30-1300 天）。在 49 例（49%）中，端口被择期移除，15 例（15%）死亡时端口在位，36 例（36%）仍在位且正在接受化疗，没有任何并发症。观察到的并发症包括疑似感染（4%）、端口骨折（4%）、导管血栓形成（1%）和阻塞（1%）。
如果遵循严格的无菌指南，在儿科肿瘤患者中使用端口是安全且可行的。
